Production (Stage)
Fideicomiso Irrevocable F/2061 Fhipo
BNZIF
$0.4683
-$0.0828-15.02%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -68.60% | 117.97% | |||
| Total Revenue | -68.60% | 117.97% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -68.60% | 117.97% | |||
| SG&A Expenses | -9.10% | -15.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -120.38% | 347.11% | |||
| Total Operating Expenses | -89.65% | 2,882.80% | |||
| Operating Income | 163.38% | -80.57% | |||
| Income Before Tax | 95.77% | -73.86% | |||
| Income Tax Expenses | 108.89% | -522.67% | |||
| Earnings from Continuing Operations | 80.84% | -71.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 80.84% | -71.66% | |||
| EBIT | -- | -- | |||
| EBITDA | -- | -- | |||
| EPS Basic | 13.74% | -55.06% | |||
| Normalized Basic EPS | 23.81% | -58.66% | |||
| EPS Diluted | 13.74% | -55.06% | |||
| Normalized Diluted EPS | 23.81% | -58.66% | |||
| Average Basic Shares Outstanding | 58.65% | -36.97% | |||
| Average Diluted Shares Outstanding | 58.65% | -36.97% | |||
| Dividend Per Share | 160.61% | -71.79% | |||
| Payout Ratio | -0.84% | 2.99% | |||